Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Ferrarini

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Haematologica|October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemiaJared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
American Journal of Hematology|October 10, 2012
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Giovanna Cutrona, et al.
American Journal of Hematology|April 17, 2023
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemiaFortunato Morabito, Giovanni Tripepi, Francesca Romana Mauro, et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
Leukemia|March 29, 2018
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximabMassimo Gentile, Tait D Shanafelt, Gianluigi Reda, et al.
Blood Cancer Journal|September 17, 2020
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximabMassimo Gentile, Enrica Antonia Martino, Andrea Visentin, et al.
European Journal of Haematology|July 25, 2018
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatmentMassimo Gentile, Tait D Shanafelt, Francesca Romana Mauro, et al.
The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.
American Journal of Hematology|February 13, 2021
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL studyFortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, et al.
Blood|April 9, 2020
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemiaAdalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Haematologica|October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemiaJared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
American Journal of Hematology|October 10, 2012
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Giovanna Cutrona, et al.
American Journal of Hematology|April 17, 2023
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemiaFortunato Morabito, Giovanni Tripepi, Francesca Romana Mauro, et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
Leukemia|March 29, 2018
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximabMassimo Gentile, Tait D Shanafelt, Gianluigi Reda, et al.
Blood Cancer Journal|September 17, 2020
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximabMassimo Gentile, Enrica Antonia Martino, Andrea Visentin, et al.
European Journal of Haematology|July 25, 2018
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatmentMassimo Gentile, Tait D Shanafelt, Francesca Romana Mauro, et al.
The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.
American Journal of Hematology|February 13, 2021
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL studyFortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, et al.
Blood|April 9, 2020
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemiaAdalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins, et al.
Pageof 13